Aram Oganesian Extending a Semi-Physiological PopPK Model of the Oral Fixed-Dose Combination of Cedazuridine with Decitabine in Myelodysplastic Syndrome Patients to Characterize an Acute Myeloid Leukemia Patient Population
|
Aram Oganesian Semi-Physiological PopPK Model Refined with Phase 3 Oral Fixed-Dose Combination Data of Cedazuridine with Decitabine in Myelodysplastic Syndrome Patients
|
Aram Oganesian A Population Pharmacokinetic Model of Tolinapant in Subjects with Advanced Solid Tumors and Lymphomas
|